InvestorsHub Logo
Followers 38
Posts 2285
Boards Moderated 0
Alias Born 12/23/2011

Re: SanDiegoAlan post# 31038

Wednesday, 06/28/2017 7:13:49 PM

Wednesday, June 28, 2017 7:13:49 PM

Post# of 118359
Regen has not changed course since focusing their attention on small molecule activators and inhibitors of NR2F6. The multi billion dollar veterinary market that would exist for the successful use of this medicinal chemistry is very attractive. This only makes perfect sense to conduct animal trials first as a means of introducing the lead compounds of NR2F6.